71st session of World Health Assembly Current Affairs - 2019
Category Wise PDF Compilations available at This Link
India has joined Global Antimicrobial Resistance (AMR) Research and Development (R&D) hub as a new member. The announcement in this regard was made by Department of Biotechnology, Union Ministry of Science & Technology in New Delhi on 12 September 2019.
India will be a member of the hub’s board of members of from 2019 itself.
By partnering with the hub, India looks forward to work with all partners and to boost their existing capabilities, resources and also to collectively focus on new research to address drug-resistant infections.
The issue of AMR requires global action with active participation from all world regions and One Health sectors. AMR refers to a microbe’s ability to resist the effects of drugs and medication that once could successfully treat the microbe.
Global Antimicrobial Resistance Research and Development Hub
The Global AMR R&D hub was launched in May 2018 on the sidelines of 71st session of World Health Assembly (WHA), following a call from G20 leaders in 2017.
Members: With inclusion of India, the Global Antimicrobial Resistance Research and Development hub now has 16 countries (including India), European Commission, 2 philanthropic foundations as members. It also has 4 international organisations as observers.
It is a global partnership that works to address challenges and improve coordination and collaboration in global AMR research and development
It supports global priority setting and evidence-based decision-making on allocation of resources for AMR R&D. This is done by identifying gaps, overlaps as well as potential for cross-sectoral collaboration and leveraging.
Global AMR R&D Secretariat: It is established in Berlin, Germany. Its secretariat supports the hub’s operations and is currently financed through grants from German Federal Ministry of Education and Research (BMBF) and Federal Ministry of Health (BMG).